Table 3.
Variation in chemotherapy regimen among various studies.
| Study | No. of cycles | Schedule (3/4 weekly) | Dose of gemcitabine | Dose of cisplatin | DI for gemcitabine (%) | DI for cisplatin (%) |
|---|---|---|---|---|---|---|
| Kim et al. [12] | 3.2 | – | – | – | – | – |
| van de Putte et al. [13] | 3 | 3 | 1000 mg/m2 | 70 mg/m2 | – | – |
| Galsky et al. [14] | 3 | – | – | – | – | – |
| Gandhi et al. [15] | 3,4 | 3,4 | 1000 mg/m2 | 70/35 mg/m2 | – | – |
| Chau et al. [16] | 3,4 | 3 | 1000 mg/m2 | 70 mg/m2 | – | – |
| Khaled et al. [17] | 3 | 3 | 1250 mg/m2 | 70 mg/m2 | – | – |
| Fairey et al. [18] | 4 | 3 | – | – | – | – |
| Pal et al. [19] | 3,4 | 4,3 | – | – | 93 | 93 |
| Matsubara et al. [20] | 4 | 4 | 1000 mg/m2 | 70 mg/m2 | – | – |
| Scosyrev et al. [21] | 2,3,4 | 3 | 2000 mg/m2 | 70 mg/m2 | – | – |
| Kaneko et al. [22] | 2 | 4 | 1000 mg/m2 | 70 mg/m2 | 83.8 | 95.4 |
| Dash et al. [7] | 4 | 3 | 615 mg/m2 weekly | 21 mg/m2 weekly | 90 | 91 |
| Herchenhorn et al. [23] | 3 | 3 | 1200 mg/m2 | 75 mg/m2 | – | – |
DI, drug intensity; –, not available.